Russian Federation vs South-East Asia (WHO region): Cases started on MDR-TB treatment
Russian Federation
23,722
in 2024
South-East Asia (WHO region)
57,653
in 2024
Russian Federation rank
2nd
South-East Asia (WHO region) rank
3rd
Cases started on MDR-TB treatment over time
- Russian Federation
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 57,653 against 23,722 in Russian Federation, a difference of 33,931.
That makes South-East Asia (WHO region)'s figure about 2.4 times Russian Federation's.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Russian Federation ahead.
Russian Federation ranks 2nd and South-East Asia (WHO region) ranks 3rd of 193 countries.
Across the 3 decades both report, Russian Federation averaged higher in 1 and South-East Asia (WHO region) in 2.
Head to head by decade
| Decade | Russian Federation | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8,143 | 2,020 | 6,123 | Russian Federation |
| 2010s | 22,358 | 30,839 | 8,481 | South-East Asia (WHO region) |
| 2020s | 28,285 | 59,055 | 30,770 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Russian Federation or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 57,653 against 23,722 in Russian Federation as of 2024.
- What is the difference in cases started on mdr-tb treatment between Russian Federation and South-East Asia (WHO region)?
- 33,931, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for Russian Federation and South-East Asia (WHO region)?
- 16 years are reported by both, from 2009 to 2024.
- How do Russian Federation and South-East Asia (WHO region) rank globally for cases started on mdr-tb treatment?
- Russian Federation ranks 2nd and South-East Asia (WHO region) ranks 3rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.